Restructuring events
European Restructuring Monitor (ERM)
The restructuring events database contains factsheets with data on large-scale restructuring events reported in the principal national media and company websites in each EU Member State. This database was created in 2002.
Leo Pharma, a multinational Danish manufacturer of pharmaceuticals, has announced the company will cut 300 jobs from it's Danish workforce. The restructuring is a result of the closure of their Ballerup research department which had 300 workers, including researchers, support and distribution staff. The closure of the research department is part of the company's new strategy, outsourcing innovation and research externally. Further, the future strategy for the company is to manufacture pharmaceuticals on license from other biotek companies.
Leo Pharma has a presence in more than 100 countries and employs around 1700 people in Denmark.
A previous restructuring event was recorded in the ERM Events database for Leo Pharma. In 2022, the company announced a global restructuring which will impact 1000 employees from 2022-2024 (Leo Pharma-2022-WO).
Eurofound (2023), Leo Pharma, Internal restructuring in Denmark, factsheet number 108214, European Restructuring Monitor. Dublin, https://apps.eurofound.europa.eu/restructuring-events/detail/108214.